This activity leads to depletion of the stromal cells that include PDGFRα+ CD140a+ mesenchymal stem cells and α-SMA+ cancer-associated fibroblasts that ultimately results in reduction of tumor growth, invasion, and metastasis (114). The gene discussed is PDGFRA; the disease is neoplasm.